1. A non‐randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing‐remitting multiple sclerosis patients. Issue 1 (8th April 2019) Authors: Mazdeh, Mehrdokht; Kargar Monhaser, Shahriar; Taheri, Mohammad; Ghafouri‐Fard, Soudeh Journal: Clinical and translational medicine Issue: Volume 8:Issue 1(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association between methylene tetrahydrofolate reductase polymorphisms and risk of ischemic stroke. (2nd January 2021) Authors: Mazdeh, Mehrdokht; Khazaie, Mojtaba; Omrani, Mir Davood; Noroozi, Rezvan; Komaki, Alireza; Karimi, Masoud; Taheri, Mohammad; Ghafouri-Fard, Soudeh Journal: International journal of neuroscience Issue: Volume 131:Number 1(2021) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial. (29th July 2022) Authors: Mazdeh, Mehrdokht; Abolfathi, Parnaz; Sabetghadam, Maryam; Mohammadi, Younes; Mehrpooya, Maryam Other Names: J. L Franco Academic Editor. Journal: Oxidative medicine and cellular longevity Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack. Issue 1 (4th March 2019) Authors: Khazaei, Mojtaba; Ghasemian, Fateme; Mazdeh, Mehrdokht; Taheri, Mohammad; Ghafouri‐Fard, Soudeh Journal: Clinical and translational medicine Issue: Volume 8:Issue 1(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cytokine profile in autistic patients. (August 2018) Authors: Eftekharian, Mohammad Mahdi; Ghafouri-Fard, Soudeh; Noroozi, Rezvan; Omrani, Mir Davood; Arsang-jang, Shahram; Ganji, Maziar; Gharzi, Vajiheh; Noroozi, Hanieh; Komaki, Alireza; Mazdeh, Mehrdokht; Taheri, Mohammad Journal: Cytokine Issue: Volume 108(2018) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Determination of cytokine levels in multiple sclerosis patients and their relevance with patients' response to Cinnovex. (August 2017) Authors: Taheri, Mohammad; Ghafouri-Fard, Soudeh; Solgi, Ghasem; Sayad, Arezou; Mazdeh, Mehrdokht; Omrani, Mir Davood Journal: Cytokine Issue: Volume 96(2017) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Expression analysis of cytokine coding genes in epileptic patients. (October 2018) Authors: Mazdeh, Mehrdokht; Omrani, Mir Davood; Sayad, Arezou; Komaki, Alierza; Arsang-Jang, Shahram; Taheri, Mohammad; Ghafouri-Fard, Soudeh Journal: Cytokine Issue: Volume 110(2018) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. GAS5 genomic variants and risk of multiple sclerosis. (14th May 2019) Authors: Mahdi Eftekharian, Mohammad; Noroozi, Rezvan; Komaki, Alireza; Mazdeh, Mehrdokht; Taheri, Mohammad; Ghafouri-Fard, Soudeh Journal: Neuroscience letters Issue: Volume 701(2019) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Glutamate receptor, metabotropic 7 (GRM7) gene variations and susceptibility to autism: A case–control study. Issue 11 (17th June 2016) Authors: Noroozi, Rezvan; Taheri, Mohammad; Movafagh, Abolfazl; Mirfakhraie, Reza; Solgi, Ghasem; Sayad, Arezou; Mazdeh, Mehrdokht; Darvish, Hossein Journal: Autism research Issue: Volume 9:Issue 11(2016) Page Start: 1161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis. (April 2016) Authors: Mazdeh, Mehrdokht; Taheri, Mohammad; Sayad, Arezou; Bahram, Siamak; Omrani, Mir Davood; Movafagh, Abolfazl; Inoko, Hidetoshi; Akbari, Mohammad Taghi; Noroozi, Rezvan; Hajilooi, Mehrdad; Solgi, Ghasem Journal: Pharmacogenomics Issue: Volume 17:Number 5(2016) Page Start: 489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗